215
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Increased neuroplasticity may protect against cardiovascular disease

, &
Pages 599-608 | Received 10 Oct 2012, Accepted 12 Mar 2013, Published online: 26 Apr 2013

References

  • Bavelier D, Neville HJ. Cross-modal plasticity: where and how? Nat Rev Neurosci 2002;3:443–52.
  • Zheng Z, Xu F. Neuroplasticity may play a role in inter-individual difference among neuropsychiatric disease treatment efficacy. Dev Psychobiol 2012;54:369–71.
  • Fraga MF, Ballestar E, Paz MF, Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 2005;102:10604–9.
  • Bulik CM, Wade TD, Kendler KS. Characteristics of monozygotic twins discordant for bulimia nervosa. Int J Eat Disord 2001;29:1–10.
  • Cannon TD, Huttunen MO, Lonnqvist J, The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia. Am J Hum Genet 2000;67:369–82.
  • Gourovitch ML, Torrey EF, Gold JM, Neuropsychological performance of monozygotic twins discordant for bipolar disorder. Biol Psychiatry 1999;45:639–46.
  • Hall LS, Love CT. Finger-length ratios in female monozygotic twins discordant for sexual orientation. Arch Sex Behav 2003;32:23–8.
  • Kolb B, Teskey GC. Age, experience, injury, and the changing brain. Dev Psychobiol 2012;54:369–71.
  • Cramer SC, Sur M, Dobkin BH, Harnessing neuroplasticity for clinical applications. Brain 2011;134:1591–609.
  • Liu RT, Alloy LB. Stress generation in depression: a systematic review of the empirical literature and recommendations for future study. Clin Psychol Rev 2010;30:582–93.
  • Morina N, von Lersner U, Prigerson HG. War and bereavement: consequences for mental and physical distress. PLoS One 2011;6:e22140.
  • Liu M, Wang L, Shi Z, Mental health problems among children one-year after Sichuan earthquake in China: a follow-up study. PLoS One 2011;6:e14706.
  • Johansson M, Ryden A, Finizia C. Mental adjustment to cancer and its relation to anxiety, depression, HRQL and survival in patients with laryngeal cancer –a longitudinal study. BMC Cancer 2011;11:283.
  • Calabrese F, Molteni R, Riva MA. Antistress properties of antidepressant drugs and their clinical implications. Pharmacol Ther 2011;132:39–56.
  • Hafner S, Baumert J, Emeny RT, To live alone and to be depressed, an alarming combination for the renin-angiotensin-aldosterone-system (RAAS). Psychoneuroendocrinology 2011;37:230–7.
  • Yu LL, Liu RP, Gao XY, Development of studies on neurochemical mechanism of acupuncture underlying improvement of depression. Zhen Ci Yan Jiu 2011;36:383–7.
  • Aihara M, Ida I, Yuuki N, HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions. Psychiatry Res 2007;155:245–56.
  • Tang SW, Helmeste D, Leonard B. Is neurogenesis relevant in depression and in the mechanism of antidepressant drug action? A critical review. World J Biol Psychiatry 2012;13:402–12.
  • Masi G, Brovedani P. The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression. CNS Drugs 2011;25:913–31.
  • Llorens-Martin M, Trejo JL. Mifepristone prevents stress-induced apoptosis in newborn neurons and increases AMPA receptor expression in the dentate gyrus of C57/BL6 mice. PLoS One 2011;6:e28376.
  • O'Sullivan E, Barrett E, Grenham S, BDNF expression in the hippocampus of maternally separated rats: does Bifidobacterium breve 6330 alter BDNF levels? Benef Microbes 2011;2:199–207.
  • Maes M, Yirmyia R, Noraberg J, The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 2009;24:27–53.
  • Sterner EY, Kalynchuk LE. Behavioral and neurobiological consequences of prolonged glucocorticoid exposure in rats: relevance to depression. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:777–90.
  • McEwen BS. Mood disorders and allostatic load. Biol Psychiatry 2003;54:200–7.
  • Sousa N, Cerqueira JJ, Almeida OF. Corticosteroid receptors and neuroplasticity. Brain Res Rev 2008;57:561–70.
  • Fitzsimons CP, van Hooijdonk LW, Morrow JA, Antiglucocorticoids, neurogenesis and depression. Mini Rev Med Chem 2009;9:249–64.
  • Jeanneteau FD, Lambert WM, Ismaili N, BDNF and glucocorticoids regulate corticotrophin-releasing hormone (CRH) homeostasis in the hypothalamus. Proc Natl Acad Sci USA 2012;109:1305–10.
  • Sousa N, Almeida OF. Corticosteroids: sculptors of the hippocampal formation. Rev Neurosci 2002;13:59–84.
  • Garcia A, Steiner B, Kronenberg G, Age-dependent expression of glucocorticoid- and mineralocorticoid receptors on neural precursor cell populations in the adult murine hippocampus. Aging Cell 2004;3:363–71.
  • Lee TH, Kato H, Chen ST, Expression disparity of brain-derived neurotrophic factor immunoreactivity and mRNA in ischemic hippocampal neurons. Neuroreport 2002;13:2271–5.
  • Ward MP, Irazoqui PP. Evolving refractory major depressive disorder diagnostic and treatment paradigms: toward closed-loop therapeutics. Front Neuroeng 2010;3:7.
  • Numakawa T, Suzuki S, Kumamaru E, BDNF function and intracellular signaling in neurons. Histol Histopathol 2010;25:237–58.
  • Castren E, Rantamaki T. Role of brain-derived neurotrophic factor in the aetiology of depression: implications for pharmacological treatment. CNS Drugs 2010;24:1–7.
  • Castren E, Voikar V, Rantamaki T. Role of neurotrophic factors in depression. Curr Opin Pharmacol 2007;7:18–21.
  • Grande I, Fries GR, Kunz M, Kapczinski F. The role of BDNF as a mediator of neuroplasticity in bipolar disorder. Psychiatry Investig 2010;7:243–50.
  • Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006;59:1116–27.
  • Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997;54:597–606.
  • Numakawa T, Yokomaku D, Richards M, Functional interactions between steroid hormones and neurotrophin BDNF. World J Biol Chem 2010;1:133–43.
  • Forsgren S, Grimsholm O, Dalen T, Rantapaa-Dahlqvist S. Measurements in the blood of BDNF for RA patients and in response to anti-TNF treatment help us to clarify the magnitude of centrally related pain and to explain the relief of this pain upon treatment. Int J Inflam 2011;2011:650685.
  • Fernandes BS, Gama CS, Maria Cereser K, Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res 2011;45:995–1004.
  • Yoshimura R, Kishi T, Suzuki A, The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:1022–5.
  • Bocchio-Chiavetto L, Bagnardi V, Zanardini R, Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J Biol Psychiatry 2010;11:763–73.
  • Fink G. Stress controversies: post-traumatic stress disorder, hippocampal volume, gastroduodenal ulceration*. J Neuroendocrinol 2011;23:107–17.
  • Smith PJ, Blumenthal JA. Psychiatric and behavioral aspects of cardiovascular disease: epidemiology, mechanisms, and treatment. Rev Esp Cardiol 2011;64:924–33.
  • Bozzini S, Gambelli P, Boiocchi C, Coronary artery disease and depression: possible role of brain-derived neurotrophic factor and serotonin transporter gene polymorphisms. Int J Mol Med 2009;24:813–8.
  • Grippo AJ, Johnson AK. Biological mechanisms in the relationship between depression and heart disease. Neurosci Biobehav Rev 2002;26:941–62.
  • Penninx BW, Beekman AT, Honig A, Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 2001;58:221–7.
  • Carney RM, Freedland KE, Rich MW, Jaffe AS. Depression as a risk factor for cardiac events in established coronary heart disease: a review of possible mechanisms. Ann Behav Med 1995;17:142–9.
  • Freedland KE, Carney RM, Lustman PJ, Major depression in coronary artery disease patients with vs. without a prior history of depression. Psychosom Med 1992;54:416–21.
  • Anda R, Williamson D, Jones D, Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology 1993;4:285–94.
  • Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996;93:1976–80.
  • Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry 1998;155:4–11.
  • Carney RM, Rich MW, Freedland KE, Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988;50:627–33.
  • Barefoot JC, Helms MJ, Mark DB, Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996;78:613–7.
  • Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993;270:1819–25.
  • Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995;91:999–1005.
  • Grippo AJ, Johnson AK. Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress 2009;12:1–21.
  • Miklos IH, Kovacs KJ. Reorganization of synaptic inputs to the hypothalamic paraventricular nucleus during chronic psychogenic stress in rats. Biol Psychiatry 2012;71:301–8.
  • Banki CM, Karmacsi L, Bissette G, Nemeroff CB. CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse. Eur Neuropsychopharmacol 1992;2:107–13.
  • Brown MR, Fisher LA, Spiess J, Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology 1982;111:928–31.
  • Ito K, Hirooka Y, Matsukawa R, Decreased brain sigma-1 receptor contributes to the relationship between heart failure and depression. Cardiovasc Res 2012;93:33–40.
  • Goodwin JE, Geller DS. Glucocorticoid-induced hypertension. Pediatr Nephrol 2012;27:1059–66.
  • Raddino R, Caretta G, Teli M, Nitric oxide and cardiovascular risk factors. Heart Int 2007;3:18.
  • Naseem KM. The role of nitric oxide in cardiovascular diseases. Mol Aspects Med 2005;26:33–65.
  • Whitworth JA, Schyvens CG, Zhang Y, The nitric oxide system in glucocorticoid-induced hypertension. J Hypertens 2002;20:1035–43.
  • Shively CA, Register TC, Clarkson TB. Social stress, visceral obesity, and coronary artery atherosclerosis: product of a primate adaptation. Am J Primatol 2009;71:742–51.
  • Bechtold AG, Scheuer DA. Glucocorticoids act in the dorsal hindbrain to modulate baroreflex control of heart rate. Am J Physiol Regul Integr Comp Physiol 2006;290: R1003–11.
  • Mattson MP, Wan R. Neurotrophic factors in autonomic nervous system plasticity and dysfunction. Neuromolecular Med 2008;10:157–68.
  • Martin JL, Jenkins VK, Hsieh HY, Balkowiec A. Brain-derived neurotrophic factor in arterial baroreceptor pathways: implications for activity-dependent plasticity at baroafferent synapses. J Neurochem 2009;108:450–64.
  • Clark CG, Hasser EM, Kunze DL, Endogenous brain-derived neurotrophic factor in the nucleus tractus solitarius tonically regulates synaptic and autonomic function. J Neurosci 2011;31:12318–29.
  • Noble EE, Billington CJ, Kotz CM, Wang C. The lighter side of BDNF. Am J Physiol Regul Integr Comp Physiol 2011;300:R1053–69.
  • Taliaz D, Loya A, Gersner R, Resilience to chronic stress is mediated by hippocampal brain-derived neurotrophic factor. J Neurosci 2011;31:4475–83.
  • Chaldakov G. The metabotrophic NGF and BDNF: an emerging concept. Arch Ital Biol 2011;149:257–63.
  • Wang C, Godar RJ, Billington CJ, Kotz CM. Chronic administration of brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus reverses obesity induced by high-fat diet. Am J Physiol Regul Integr Comp Physiol 2010;298:R1320–32.
  • Donovan MJ, Lin MI, Wiegn P, Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development 2000;127:4531–40.
  • Ejiri J, Inoue N, Kobayashi S, Possible role of brain-derived neurotrophic factor in the pathogenesis of coronary artery disease. Circulation 2005;112:2114–20.
  • Manni L, Nikolova V, Vyagova D, Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. Int J Cardiol 2005;102:169–71.
  • Jung SH, Kim J, Davis JM, Association among basal serum BDNF, cardiorespiratory fitness and cardiovascular disease risk factors in untrained healthy Korean men. Eur J Appl Physiol 2011;111:303–11.
  • Esler M, Eikelis N, Schlaich M, Human sympathetic nerve biology: parallel influences of stress and epigenetics in essential hypertension and panic disorder. Ann NY Acad Sci 2008;1148:338–48.
  • Delbin MA, Silva AS, Antunes E, Zanesco A. Interaction between serotoninergic-and beta-adrenergic receptors signaling pathways in rat femoral artery. Arq Bras Cardiol 2012;98:29–34.
  • Kasahara M, Groenink L, Olivier B, Sarnyai Z. Corticotropin-releasing factor (CRF) over-expression down-regulates hippocampal dopamine receptor protein expression and CREB activation in mice. Neuro Endocrinol Lett. 2011;32:193–8.
  • Martocchia A, Curto M, Toussan L, Pharmacological strategies against glucocorticoid-mediated brain damage during chronic disorders. Recent Pat CNS Drug Discov 2011;6:196–204.
  • Rauramaa T, Pikkarainen M, Englund E, Cardiovascular diseases and hippocampal infarcts. Hippocampus 2011;21:281–7.
  • Castle M, Comoli E, Loewy AD. Autonomic brainstem nuclei are linked to the hippocampus. Neuroscience 2005;134:657–69.
  • Blugeot A, Rivat C, Bouvier E, Vulnerability to depression: from brain neuroplasticity to identification of biomarkers. J Neurosci 2011;31:12889–99.
  • Yau SY, Lau BW, Tong JB, Hippocampal neurogenesis and dendritic plasticity support running-improved spatial learning and depression-like behaviour in stressed rats. PLoS One 2011;6:e24263.
  • Pittenger C, Duman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008;33:88–109.
  • Ondicova K, Pecenak J, Mravec B. The role of the vagus nerve in depression. Neuro Endocrinol Lett 2010;31:602–8.
  • Banasr M, Dwyer JM, Duman RS. Cell atrophy and loss in depression: reversal by antidepressant treatment. Curr Opin Cell Biol 2011;23:730–7.
  • Kitayama I, Nakamura S, Yaga T, Degeneration of locus coeruleus axons in stress-induced depression model. Brain Res Bull 1994;35:573–80.
  • Djalali S, Holtje M, Grosse G, Effects of brain-derived neurotrophic factor (BDNF) on glial cells and serotonergic neurons during development. J Neurochem 2005;92: 616–27.
  • Gould E. Serotonin and hippocampal neurogenesis. Neuropsychopharmacology 1999;21:46S–51S.
  • Rush AJ, Fava M, Wisniewski SR, Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials 2004;25:119–42.
  • Kutiyanawalla A, Terry AV Jr, Pillai A. Cysteamine attenuates the decreases in TrkB protein levels and the anxiety/depression-like behaviors in mice induced by corticosterone treatment. PLoS One 2011;6:e26153.
  • Berninger B, Schinder AF, Poo MM. Synaptic reliability correlates with reduced susceptibility to synaptic potentiation by brain-derived neurotrophic factor. Learn Mem 1999;6:232–42.
  • Thoenen H. Neurotrophins and neuronal plasticity. Science 1995;270:593–8.
  • Vanguilder HD, Bixler GV, Sonntag WE, Freeman WM. Hippocampal expression of myelin-associated inhibitors is induced with age-related cognitive decline and correlates with deficits of spatial learning and memory. J Neurochem 2012;121:77–98.
  • Heldt SA, Stanek L, Chhatwal JP, Ressler KJ. Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry 2007;12:656–70.
  • Karpova NN, Pickenhagen A, Lindholm J, Fear erasure in mice requires synergy between antidepressant drugs and extinction training. Science 2011;334:1731–4.
  • von Kanel R. Psychosocial stress and cardiovascular risk –current opinion. Swiss Med Wkly 2012;142:w13502.
  • Fisher M, Holland C, Merzenich MM, Vinogradov S. Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. Am J Psychiatry 2009;166:805–11.
  • Nathan PJ, Cobb SR, Lu B, Studying synaptic plasticity in the human brain and opportunities for drug discovery. Curr Opin Pharmacol 2011;11:540–8.
  • Kahler AK, Djurovic S, Rimol LM, Candidate gene analysis of the human natural killer-1 carbohydrate pathway and perineuronal nets in schizophrenia: B3GAT2 is associated with disease risk and cortical surface area. Biol Psychiatry 2011;69:90–6.
  • Rizos EN, Papathanasiou M, Michalopoulou PG, Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients. Schizophr Res 2011;129:201–4.
  • Xu PT, Li YJ, Qin XJ, A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease. Mol Cell Neurosci 2007;36:313–31.
  • Spires TL, Hannan AJ. Molecular mechanisms mediating pathological plasticity in Huntington's disease and Alzheimer's disease. J Neurochem 2007;100:874–82.
  • Ray M, Ruan J, Zhang W. Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases. Genome Biol 2008;9: R148.
  • Laursen TM, Munk-Olsen T, Vestergaard M. Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatry 2012;25:83–8.
  • Koizumi S, Minamisawa S, Sasaguri K, Chewing reduces sympathetic nervous response to stress and prevents poststress arrhythmias in rats. Am J Physiol Heart Circ Physiol 2011;301:H1551–8.
  • Patel KP, Zheng H. Central neural control of sympathetic nerve activity in heart failure following exercise training. Am J Physiol Heart Circ Physiol 2012;302:H527–37.
  • Xiong GL, Doraiswamy PM. Does meditation enhance cognition and brain plasticity? Ann NY Acad Sci 2009;1172:63–9.
  • Wan CY, Schlaug G. Music making as a tool for promoting brain plasticity across the life span. Neuroscientist 2010;16:566–77.
  • Using music to tune the heart. Music therapy, or just listening to music, can be good for the heart. Harv Heart Lett 2009;20:4–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.